Pune, India

Sanjay C Wagh

This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjay C Wagh. Retrieved from https://idiyas.com/inventor/sanjay-c-wagh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sanjay C Wagh: Innovator in Pharmaceutical Compositions

Introduction

Sanjay C Wagh is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work is characterized by a focus on improving the efficacy and delivery of medications.

Latest Patents

Sanjay C Wagh holds 1 patent for his invention titled "Pharmaceutical compositions of raltegravir." This patent describes a solid pharmaceutical composition for oral administration that includes raltegravir or a pharmaceutically acceptable salt thereof, an acidifying agent selected from tartaric acid, citric acid, and fumaric acid, along with one or more pharmaceutically acceptable excipients. This formulation aims to enhance the therapeutic effectiveness of raltegravir.

Career Highlights

Sanjay is currently associated with Lupin, Inc., a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in drug formulation and development, contributing to the advancement of healthcare solutions.

Collaborations

Throughout his career, Sanjay has collaborated with talented professionals, including Vikram K Karne and Avinash K Velhal. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.

Conclusion

Sanjay C Wagh's contributions to pharmaceutical compositions exemplify the importance of innovation in drug development. His work not only enhances the effectiveness of treatments but also reflects the collaborative spirit of the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…